Home › Free Stock Grades › TBPH
Theravance Biopharma Inc (TBPH) Stock Grade
TBPH · Healthcare
A+
Market Cap
$941.4M
P/E Ratio
8.9
Revenue Growth (YoY)
+66.9%
Net Margin
98.5%
Return on Equity
35.7%
Dividend Yield
None
About Theravance Biopharma Inc's fundamentals
Theravance Biopharma is a small-cap pharmaceutical company with a market capitalization of $941.4 million, currently trading at a P/E ratio of 8.9. The company demonstrated exceptional financial performance with revenue growth of 66.9% year-over-year and an exceptionally high net margin of 98.5%, indicating strong profitability relative to sales. Return on equity stands at 35.7%, suggesting efficient use of shareholder capital to generate earnings. The company does not currently pay a dividend.